MedTrace Logo

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

NCT00942344 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2009-07-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of fixed combination of amlodipine(5mg or 10mg) and losartan (50 mg or 100 mg), amlodipine and losartan alone in reducing blood pressure. The study will investigate the dose response relationship for the combinations and monotherapies.

Conditions

Interventions

DRUG

Amlodipine plus Losartan

amlodipine/losartan 5/50mg, 5/100mg, 10/50mg, 10/100mg

DRUG

Amlodipine

amlodipine 5mg, 10mg

DRUG

Losartan

Losartan 50mg, 100mg

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Principal Investigators

  • Seung-Yun Cho, M.D., Ph.D. · Severance Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • South Korea

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00942344 on ClinicalTrials.gov